TET2 and myeloid neoplasm: Myeloid Malignancy-Related Gene Mutation Screening: A panel of 67 genes associated with the diagnosis, treatment, prognosis, and recurrence of myeloid malignancies (including KIT, SRSF2, TET2, and ASXL2) was analyzed, with no relevant mutations identified.